and to promote healthy aging. “Everybody here comes to
work with the goal of trying to alleviate human suffering,”
says Institute President and CEO, Dr. Fiona Crawford,
who leads the Institute along with Dr. Michael Mullan.
Crawford and Mullan were members of a team of scientists
who discovered the onset of Alzheimer’s was, among
other things, directly related to the accumulation of a
protein called ß-amyloid. Today, the Roskamp Institute
develops medications and treatments to reduce or slow
the accumulation of ß-amyloid. A promising treatment
developed by Roskamp researchers recently concluded
testing in a Phase III clinical study in Europe. Few drugs
have advanced to this stage, and if successful, the
targets the disease itself, not just its symptoms.
DECEMBER 2017 | SARASOTA SCENE 71
Roskamp Institute
Pursuing Cures
Since opening its doors in 2003, the Roskamp Institute
has been a global leader in the search for cures for
debilitating diseases and disorders of the brain, including
Alzheimer’s disease as well as conditions that particularly
impact veterans and military personnel, such as Traumatic
Brain Injury (TBI), posttraumatic stress disorder (PTSD)
and Gulf War illness. Based in a 48,000-square-foot
passionately search for the keys that will unlock the cures
to diseases that impact millions of patients, their families
and caregivers, and an overburdened healthcare system
that will need to care for them all.
The Roskamp Institute employs highly experienced,
interdisciplinary scientists and technicians to conduct
research with a mission to discover safe, effective new
drug therapies to successfully treat diseases of the mind
CONNECT >>> 2040 Whitfield Ave., Sarasota 34243 | 941.752.2949 | roskampinstitute.org
/roskampinstitute.org